Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study. - Peeters SLJ; Heersche N; Böhm D; Böhringer S; Guiljam R; Hulshof EC; de Man FM; de With M; Joosse M; Oomens G; Wu QY; Osman A; et al. (The Lancet regional health. Europe, 2026)